Stock Region Penny Picks Newsletter - Thursday, October 24, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.
$RNAZ - TransCode Therapeutics

TransCode Therapeutics has received approval from the Safety Review Committee to open the second cohort in its Phase 1 TTX-MC138 clinical trial. This follows a positive safety review of the first cohort, potentially indicating progress in their therapeutic developments.
$VRAX - Virax Biolabs

Virax Biolabs has signed a distribution agreement to commercialize its ImmuneSelect Profiling Solutions in the UK and Ireland. This expansion could enhance their market presence and drive revenue growth.
$JZ - Jianzhi Education Technology

Jianzhi Education Technology is bolstering its EdTech capabilities with new AI integrations. This move is likely to enhance user experience and expand their educational offerings.
$WINT - Windtree Therapeutics

Windtree has announced new patent filings for Istaroxime in several countries, focusing on treatments for cardiogenic shock. This strategic move could strengthen their intellectual property portfolio and support future product launches.
$FTCI - FTC Solar

FTC Solar will supply approximately 1GW of solar projects for Sandhills Energy. This significant order underscores FTC Solar's robust pipeline and its growing footprint in the renewable energy sector.
$LRHC - La Rosa Holdings

La Rosa Holdings has reported preliminary revenues of approximately $45 million for the first nine months of 2024, reflecting a 120% year-over-year growth. This impressive growth highlights the company's strong market performance.
$TVGN - Tevogen Bio

Tevogen Bio's AI division has joined Microsoft's Startups program, aiming to accelerate drug development processes. This partnership could lead to faster and more efficient R&D initiatives.
$TSLA - Tesla (Growth Stock)

Tesla reported earnings of $0.72 per share, surpassing analyst expectations by 24.14%. Despite missing sales estimates, revenue is up 7.85% from last year, indicating strong operational performance.
$RMNI - Rimini Street

Rimini Street has partnered with ServiceNow to develop a new enterprise software model. This collaboration could unlock value in existing ERP systems and support digital growth for enterprises.
$MNDR - Mobile-health Network Solutions

Mobile-health Network Solutions has reported a 77% revenue increase for fiscal year 2024, showcasing significant growth and potential for further expansion in the mobile health sector.
$KWE - KWESST Micro Systems

KWESST has completed its volume production ramp-up for Arwen Cartridges, outsourcing with an ammunition manufacturer to meet growing demand. This marks a crucial step in scaling their operations to cater to market needs.
Disclaimer: This newsletter is for informational purposes only and does not constitute financial advice. Readers are advised to assess their investment strategies with due diligence.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net